tirzepatide court ruling Lilly Takes Four Compounders to for Allegedly Producing Knockoff A Judge Just Shut Down

It might be necessary to utilize therapies to recognize harmful eating and adapt attitudes, thought patterns, and behaviors around eating

Our multidisciplinary team helps patients across New England and beyond find balance, reverse chronic disease patterns, and reach their ideal state of well-being

Early detection and proper management of glaucoma are still the most important steps in protecting vision

[3] Next-Generation Dual and Multi-Targeted Therapies on the Rise Amycretin: A Promising Dual GLP-1/Amylin Receptor Agonist Also making headlines at ADA 2025 was Amycretin (NNC0487-0111), a novel, unimolecular GLP-1 and amylin receptor agonist under development by Novo Nordisk

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes